The return of the Scarlet Pimpernel: Cobalamin in inflammation II - Cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS

Journal of Nutritional and Environmental Medicine

Volumn 16, Issue 3-4, 2007, Pages 181-211

  Wheatley, Carmen ^a  

^a Orthomolecular Oncology   (United Kingdom)

Author keywords

Adenosylcobalamin; Aquacobalamin; Cobalamin; Glutathionylcobalamin; GSNO; Inflammation; Interferon; IRF 1; Methylcobalamin; Nitric oxide; Nitrosylcobalamin; Selective promotion inhibition nitric oxide synthases; Transcobalamins; Tumour necrosis factor alpha

Indexed keywords

ACONITATE HYDRATASE; ARGININE; COBALAMIN; COBAMAMIDE; CYTOCHROME C OXIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; FOLIC ACID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; HEME; HYDROXOCOBALAMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MECOBALAMIN; METHIONINE SYNTHASE; METHYLMALONYL COENZYME A MUTASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTOSE PHOSPHATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; S NITROSOTHIOL; TRICARBOXYLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYANIDE POISONING; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PERNICIOUS ANEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SHOCK; SIGNAL TRANSDUCTION; SPINAL CORD ATROPHY; UREA CYCLE;

ANAGALLIS ARVENSIS;

EID: 38849202297     PISSN: 13590847     EISSN: 13646907     Source Type: Journal    
DOI: 10.1080/10520290701791839     Document Type: Article

References (243)

1. Wheatley C. A Scarlet Pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Med Hypotheses 2006;67:124-42.
2. Wheatley C. A unified theory of the causes of monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma, with a consequent treatment proposal for long-term control and possible cure. J Orthomol Med 2002;17:7-16.
3. Olesen H, Andersen MP, Amris A. Serum vitamin B12 binding capacity in patients with anaemia. Scand J Haematol 1968;5:235-40.
4. Seetharam B, Li N. Transcobalamin II and its cell surface receptors. Vitam Horm 2000;59:337-66.
5. Ghosh K, Mohanty D, Rana KS, et al. Plasma transcobalamins in haematological disorders. Folia Haematol Int Mag Klin Morphol Blutforsch 1986;113:766-75.
6. Christensen PA, Brynskov J, Gimsing P, Petersen J. Vitamin B12 binding proteins (transcobalamin and haptocorrin) in serum and synovial fluid of patients with rheumatoid arthritis and traumatic synovitis. Scand J Rheumatol 1983;12:268-72.
7. Lasser U, Kierat L, Grob P, et al. Transcobalamin II, a serum protein reflecting autoimmune disease activity, its plasma dynamics, and the relationship to established serum parameters in systemic lupus erythematosus. Clin Immunol Immunopathol 1985;36:345-57.
8. Rachmilewitz D, Ligumsky M, Rachmilewitz B, et al. Transcobalamin II level in peripheral blood monocytes - a biochemical marker in inflammatory diseases of the bowel. Gastroenterology 1980;78:43-6.
9. Nexø E, Olesen H. Intrinsic factor, transcobalamin, and haptocorrin. In: Dolphin D, editor. B12, biochemistry and medicine. New York: Wiley-Interscience; 1982. pp 57-85.
10. Macdonald C, Bessent R, Adams J. Transcobalamin-binding capacities in vitamin B12-related diseases. Am J Clin Pathol 1981;75:677-83.
11. Carmel R, Eisenberg L. Serum B12 and transcobalamin abnormalities in people with cancer. Cancer 1977;40:1348-53.
12. Carmel R, Hollander H. Extreme elevations of transcobalamin II levels in multiple myeloma and other disorders. Blood 1978;51:1057-63.
13. Rachmilewitz B, Sulkes A, Rachmilewitz M, Fuks Z. Serum transcobalamin II levels in breast carcinoma patients. Isr J Med Sci 1981;17:874-8.
14. Baeuerle P, Baltimore D. Meeting review. NFκB ten years after. Cell 1996;87:13-20.
15. Kleinwort H, Schwarz PM, Förstermann U. Regulation of the expression of inducible nitric oxide synthase. J Biol Chem 2003;384:1343-64.
16. Wagener FADTG, Volk H-D, Willis D. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003;55:551-71.
17. Wheatley C, Perretti M, D'Acquisto F, Sampaio ALF, et al. 2006 (in preparation).
18. Perretti M, Wheatley C, D'Acquisto F, Sampaio ALF, et al. 2007 (in preparation).
19. Griscavage JM, Fukuto JM, Komori Y, Ignarro LJ. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. J Biol Chem 1994;269(34):21644-9.
20. Albakri QA, Stuehr DJ. Intracellular assembly of inducible NO synthase is limited by nitric oxide - mediated changes in heme insertion and availability. J Biol Chem 1996;271(10):5414-21.
21. Peng H-B, Spiecker M, Liao JK. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol 1998;161:1970-6.
22. Mathews JR, Botting CH, Panico M, Morriss HR, Hay RT. Inhibition of NFκB binding by nitric oxide. Nucleic Acids Res 1996;24:2236-42.
23. Markle HV. Cobalamin. Crit Rev Clin Lab Sci 1996;33:247-56.
24. Banerjee R (ed.). Chemistry and biochemistry of B12. New York: Wiley Interscience; 1999. pp 1-921.
25. Nexø E. Cobalamin binding proteins. In: Kräutler B, Arigoni D, Golding BT, editors. Vitamin B12 and B12 proteins La Jolla: Wiley; 1998. pp 461-75.
26. Beck WS. Biological and medical aspects of vitamin B12. In: Dolphin D, editor. B12, biochemistry and medicine. New York: Wiley-Interscience; 1982. pp 1-30.
27. Seetharam B. Receptor-mediated endocytosis of cobalamin (vitamin B12). Annu Rev Nutr 1999;19:173-95.
28. Ostray F, Gams RA. Cellular fluxes of vitamin B12. Blood 1997;50:877-88.
29. Moestrup SK. Cellular surface receptors important for vitamin B12 nutrition. In: Kräutler B, Arigoni D, Golding BT, editors. Vitamin B12 and B12 proteins. La Jolla: Wiley; 1998. pp 477-89.
30. Carmel R. The distribution of endogenous cobalamin among cobalamin-binding proteins in the blood in normal and abnormal states. Am J Clin Nutr 1985;41:713-9.
31. Zittoun J, Marquet J, Zittoun R. The intracellular content of the three transcobalamins at various stages of normal and leukaemic myeloid cell development. Br J Haematol 1975;31:299-310.
32. Herbert V. B12 deficiency in AIDS. J Am Med Assoc 1988;260:2837.
33. Carmel R, Eisenberg L. Serum B12 and transcobalamin abnormalities in people with cancer. Cancer 1977;40:1348-53.
34. Lindenbaum J, Rosenberg IH, Wilson PW, et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994;60:2-11.
35. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002;28:108-21.
36. Brasch NE, Hsu T, Doll KM, Finke RG. Synthesis and characterization of isolable thiolatocobalamin complexes relevant to coenzyme B12-dependent ribonucleotide triphosphate reductase. J Inorg Biochem 1999;76:197-209.
37. Suto RK, Brasch NE, Anderson OP, Finke RG. Synthesis, characterization, solution stability and X-ray crystal structure of the thiolatocobalamin γ-glutamylcysteinylcobalamin, a dipeptide analog of glutathionylcobalamin: insights into the enhanced Co-S bond stability of the natural product glutathionylcobalamin. Inorg Chem 2001;40:2686-92.
38. Xia L, Cregan AG, Berben LA, Brasch NE. Studies on the formation of glutathionylcobalamin: any free intracellular aquacobalamin is likely to be rapidly and irreversibly converted to glutathionylcobalamin. Inorg Chem 2004;43:6848-57.
39. Dubnoff JW. A cobalamin glutathione complex. Biochem Biophys Res Commun 1964;16(5):484-8.
40. Adler N, Medwick T, Poznanski TJ. Reaction of hydroxocobalamin with thiols. J Am Chem Soc 1966;88(21):5018-20.
41. Jacobsen DW, Lee-Denison C, Luce K, Green R. Glutathionylcobalamin (GSCbl) is found in cultured and ascites leukemia-L1210 cells. Fed Proc 1987;46:1005.
42. Pezacka E, Green R, Jacobsen DW. Glutathionylcobalamin as an intermediate in the formation of cobalamin coenzymes. Biochem Biophys Res Comm 1990;169(2):443-50.
43. Kim JH, Demaurex N, Grinstein S. Intracellular pH: measurement, manipulation and physiological regulation. In: Koning WN, Kaback HR, Lolkema JS, editors. Handbook of biological physics, Vol. 2. Amsterdam: Elsevier Science; 1996. pp 447-72.
44. Luschinsky Drennan C, Huang S, Drummond JT, Matthews RG, Ludwig ML. How a protein binds B12: a 3.0Å X-ray structure of B12-binding domains of methionine synthase. Science 1994;266:1669-74.
45. Mancia F, Keep NH, Nakagawa A, et al. How coenzyme B12 radicals are generated: the crystal structure of methylmalonyl-coenzyme A mutase at 2Å resolution. Structure 1996;4(3):339-49.
46. Sirovatka JM, Finke RG. Coenzyme B12 chemical precedent studies: probing the role of the imidazole baseon motif found in B12-dependent methylmalonyl-CoA mutase. J Am Chem Soc 1997;119:3057-67.
47. Poston JM. β-leucine and the β-keto pathway of leucine metabolism. Adv Enzymol 1986;58:173-89.
48. Stabler SP, Lindenbaum J, Allen RH. Failure to detect β-leucine in human blood or leucine 2, 3-aminomutase in rat liver using capillary gas chromatography-mass spectrometry. J Biol Chem 1988;263(12):5581-8.
49. Metz J, Kelly A, Chapin Swett V, Waxman S, Herbert V. Deranged DNA synthesis by bone marrow from vitamin B12 deficient humans. Br J Haematol 1968;14:575-91.
50. Mason JB, Levesque T. Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology 1996;10:1727-43.
51. Beattie DS. Bioenergetics and oxidative metabolism. In: Devlin TM, editor. Textbook of biochemistry, with clinical correlations New York: Wiley-Liss; 2006. pp 531-80.
52. Parker JN, Parker PM. Vitamin B12, a medical dictionary, bibliography, and annotated research guide to Internet references. ICON Group International; 2004. pp 1-344.
53. Riou B, Gérard JL, Drieu la Rochelle C, et al. Hemodynamic effects of hydroxocobalamin in conscious dogs. Anaesthesia 1991;74:552-8.
54. Rajanayagam MAS, Li CG, Rand MJ. Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle. Br J Pharmacol 1993;108:3-5.
55. Greenberg SS, Zie J, Zatarain JM, et al. Hydroxocobalamin (vitamin B12) prevents and reverses endotoxin-induced hypertension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther 1995;273:257-65.
56. Kruszyna R, Kruszyna H, Smith RP, Thron CD, Wilcox DE. Nitrite conversion to nitric oxide in red cells and its stabilisation as a nitrosylated valency hybrid of hemoglobin. J Pharmacol Exp Ther 1987;241:307-13.
57. Rochelle LG, Morana SJ, Kruszyna H, et al. Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther 1995;275:48-52.
58. Brouwer M, Chamulitrat W, Ferruzzi G, Sauls DL, Weinberg JB. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 1996;88(5):1857-64.
59. Zheng D, Yan L, Birke RL. Electrochemical and spectral studies of the reactions of aquacobalamin with nitric oxide and nitrite ion. Inorg Chem 2003;41:2548-55.
60. Kruszyna H, Magyar J, Rochelle LG. Spectroscopic studies of nitric oxide (NO) interactions with cobalamins: reaction of NO with superoxocobalamin(II) likely accounts for cobalamin reversal of the biological effects of NO. J Pharmacol Exp Ther 1998;285:665-71.
61. Wolak M, Stochel G, Hamza M, Van Eldik R. Aquacobalamin (vitamin B12a) does not bind NO in aqueous solution. Nitrite impurities account for observed reaction. Inorg Chem 2000;39:2018-9.
62. Zheng D, Birke RL. The reaction of nitric oxide with glutathionylcobalamin. J Am Chem Soc 2002;124:9066-7.
63. Danishpajooh IO, Gudi T, Yongchang C, et al. Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway. J Biol Chem 2001;276(29):27296-303.
64. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992;258:1898-902.
65. Bauer J, Morrison BH, Grane R, et al. Effects of interferon β on transcobalamin II-receptor expression and anti-tumor activity of nitrosylcobalamin. J Natl Cancer Inst 2002;94(13):1010-9.
66. Mushett CW, Kelly KL, Boxer GE, et al. Antidotal efficacy of vitamin B12 (hydroxocobalamin) in experimental cyanide poisoning. Proc Soc Exp Biol Med 1952;81:234-7.
67. Traina V. Vitamin B12 as an anti-anaphylactic. Nature 1950;166:78-9.
68. Badyuzin IS. The anti-shock activity of large doses of cyanocobalamin. Byull Eksp Biol Med 1965;60:62-4.
69. Posner MA, Rodkey FL, Tobey RE. Nitroprusside-induced cyanide poisoning: antidotal effect of hydroxocobalamin. Anaesthesia 1976;44:330-5.
70. Mitrofanov VG. The pathogenesis of traumatic shock and its complication with radiation sickness. Diss dokt, Leningrad; 1959 [in Russian].
71. Lazarev NV, Vishniakov SM. Problem of increasing resistance of the organism to operative trauma by medical means. Vestn Khir 1957;79(11):19-23 [in Russian].
72. Yacoub M, Faure H, Morena M, et al. L'intoxication cyanhydrique aiguë. Données actuelles sur le métabolisme du cyanure et le traitement par hydroxocobalamine. J Europ de Toxicol 1974;7:22-9.
73. Motin J, Bouletrean P, Rouzious JM. Intoxication cyanhydrique grave traitée avec succès par hydroxocobalamine. J Med de Strasbourg 1970;I:717-22.
74. Tassan H, Joyon D, Richard T, et al. Intoxication au cyanure de potassium traitée par l'hydroxocobalamine. Ann Fr Anesth Reanim 1990;9:383-5.
75. Brouard A, Blaisot B, Bismuth C. Hydroxocobalamine in cyanide poisoning. J Toxicol Clin Exp 1987;7:155-68.
76. Hall AH, Rumack BH. Hydroxocobalamin/sodium thiosulfate as a cyanide antidote. J Emerg Med 1987;5:115-21.
77. Forsyth JC, Mueller PD, Becker CE, et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. Clin Toxicol 1993;31:277-94.
78. Wheatley C. A novel approach to the treatment of septic shock? J Nutr Environ Med 2004;14(1):56-7.
79. Nathan C. Points of control in inflammation. Nature, Inflammation 2002;420:846-52.
80. Henson PM. Editorial: Get the balance right. Dampening inflammation. Nature Immunol 2005;6:1177-81.
81. MacMicking J, Xie Q, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.
82. Hamers MN, Roos D. Oxidative stress in human neutrophilic granulocytes: host defence and self-defence. In: Sies H, editor. Oxidative stress. London: Academic Press; 1985. pp 351-81.
83. Flohé L, Beckmann R, Giertz H, et al. Oxygen-centered free radicals as mediators of inflammation. In: Sies H, editor. Oxidative stress. London: Academic Press; 1985. pp 403-36.
84. Deora AA, Lauder HM. Role of nitric oxide and other radicals in signal transduction. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 251-63.
85. Darley-Usmar VM, Patel RP, O'Donnell VB, Freeman BA. Antioxidant actions of nitric oxide. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 265-76.
86. Stamler JS, Lamas S, Fang FC. Meeting review. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 2001;106:675-83.
87. Sies H. Oxidative stress: introductory remarks. In: Sies H, editor. Oxidative stress. London: Academic Press; 1985. pp 1-8.
88. Scandalios JG (ed.). Oxidative stress and the molecular biology of antioxidant defenses. New York: Cold Spring Harbour; 1997.
89. Wolin MS, Mohazzab-H KM. Mediation of signal transduction by oxidants. In: Scandalios JG, editor. Oxidative stress and the molecular biology of antioxidant defenses. New York: Cold Spring Harbour; 1997. pp 21-48.
90. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605.
91. Meister A. On the biochemistry of glutathione. In: Tamiguchi N, Higashi T, Sakanoto Y, Meister A, editors. Glutathione centennial, molecular perspectives and clinical implications. New York: Academic Press; 1989. pp 1-21.
92. Peunora N, Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature 1993;364:450-3.
93. Greenberg DA. Bilirubin and the brain. Sci Med 2003;9:96.
94. Schwarz NB. Carbohydrate metabolism II: special pathways and glycoconjugates. In: Devlin TM, editor. Textbook of biochemistry, with clinical correlations. New York: Wiley-Liss; 2006. pp 637-60.
95. Borovikova LV, Lvanona S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-62.
96. Damazo AS, Yona S, D'Acquisto F, Flower RJ, Oliani SM, Perretti M. Critical protective role for Annexin I gene expression in the endotoxemic murine microcirculation. Am J Pathol 2005;166:1607-17.
97. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New Engl J Med 1989;320:265-71.
98. Serhan CN, Gotlinger K, Hong S, et al. Anti-inflammatory actions of neuroprotectin DI/protectin DI and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 2006;176:1848-59.
99. Serhan CN, Clish CB, Brannon J, et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000;192:1197-204.
100. Ramstedt U, Janet NG, Wigzell H, Serhan CN, Samuelson B. Action of novel eicosanoids lipoxin A and B on human natural killer cell toxicity: effects on intracellular cAMP and target cell binding. J Immunol 1985;135:3434-8.
101. Ajuebor MN, Das AM, Virag L, Flower RJ, Szabó C, Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999;162:1685-91.
102. Wahl SM. Regulation of tissue inflammation, repair, and fibrosis by transforming growth factor beta. In: Luger TA, Schwarz T, editors. Epidermal growth factors and cytokines. New York: Marcel Dekker; 1994. pp 241-52.
103. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NFκB in the resolution of inflammation. Nature Med 2001;7(12):1291-7.
104. Llesuy S, Evelson P, Gonzalez-Flecha B, et al. Oxidative stress in muscle and liver of rats with septic syndrome. Free Radic Biol Med 1994;16:445-51.
105. Poderoso JJ, Carreras MC, Lisdero C, et al. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 1996;328(1):85-92.
106. Ruetten H, Thiemermann C. Nitric oxide and septic shock. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 747-57.
107. Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000;161:1781-5.
108. Evans TJ, Cohen J. Mediators: nitric oxide and other toxic oxygen species. In: Rietschel ET, Wagner H, editors. Pathology of septic shock. Berlin: Springer; 1996. pp 189-208.
109. Schmidt HW, Hofmann H, Schindler U, et al. No •NO from NO synthase. Proc Natl Acad Sci 1996;93:14492-7.
110. Vallance P. Assessment of nitric oxide in humans. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 923-4.
111. Fukuto JM, Cho JY, Switzer CH. The chemical properties of nitric oxide and related nitrogen oxides. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 23-40.
112. Weinberg JB, Lang T, Wilkinson WE, Pisetsky DS, St Clair WE. Serum, urinary and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures. Arthritis Res Ther 2006;8:R140.
113. Coomes MW. Amino acid metabolism. In: Devlin TM, editor. Textbook of biochemistry, with clinical correlations. New York: Wiley-Liss; 2006. pp 743-87.
114. Kaeseler Andersen S, Gjedsted J, Christiansen C, Tonnesen E. The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukocyte Biol 2004;75:413-21.
115. G-methyl-l-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990;172:1132-8.
116. Florquin S, Amraoui Z, Dubois C, Decuyper J, Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med 1994;180:1153-8.
117. Kamijo R, Harada H, Matsuyama M, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994;263:1612-5.
118. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
119. Vodovotz Y, Kopp JB, Takeguchi H, et al. Increased mortality, blunted production of nitric oxide, and increased production of TNF-alpha in endotoxemic TGF-beta1 transgenic mice. J Leukocyte Biol 1998;63:31-9.
120. Peracchi M, Bamonti Catena F, Pomati M, et al. Human cobalamin deficiency: alterations in serum tumour necrosis factor-α and epidermal growth factor. Eur J Haematol 2001;67:123-7.
121. Wang S, Wang W, Wesley RA, Danner RL. A Sp1 binding site of the TNFα promoter functions as a nitric oxide response element. J Biol Chem 1999;274:33190-3.
122. Pardali K, Kurisaki A, Moren A. Role of Smad proteins and transcription factor Sp1 in p21 (Waf1/Cip1) regulation of TGFβ. J Biol Chem 2000;275:29244-56.
123. Merchant JL, Shiotani A, Mortensen ER, et al. Epidermal growth factor stimulation of the human gastrin promoter requires Sp1. J Biol Chem 1995;270:6314-9.
124. Reinhart K, Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 2001;29:S121-5.
125. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci 1995;92:10688-92.
126. MacMicking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;81:641-50.
127. McCaddon A, Regland B, Hudson P, Davies G. Functional vitamin B12 deficiency and Alzheimer disease. Neurology 2002;58:1395-9.
128. Hobbs MR, Udhayakumar V, Levesque M, et al. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 2002;360:1468-75.
129. Nathan C. Natural resistance and nitric oxide. Cell 1995;82:873-6.
130. Force RW, Nahata MC. Effect of histamine H2-receptor antagonists on vitamin B12 absorption. Ann Pharmacother 1992;10:1283-6.
131. Ruscin MJ, Page RL, Valuck RJ. Vitamin B12 deficiency associated with histamine 2-receptor antagonists and a proton-pump inhibitor. Ann Pharmacother 2002;36:812-6.
132. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 1996;20:443-8.
133. Kinoshita H, Tsutsui M, Milstien S, Katusic ZS. Tetrahydrobiopterin, nitric oxide and regulation of cerebral vascular tone. Prog Neurobiol 1997;52:295-302.
134. Mayer B, Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 1997;22:477-81.
135. Rusche KM, Spiering MM, Marletta MA. Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase. Biochemistry 1998;37:15503-12.
136. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function, and inhibition. Biochem J 2001;357:593-615.
137. Ma XL, Gao F, Liu G-L, et al. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci 1999;96:14617-22.
138. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-6.
139. Wolin MS. Mechanisms through which reactive nitrogen and oxygen species interact with physiological signaling systems. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 277-92.
140. 2 peptide. Proc Natl Acad Sci 1996;93:3377-82.
141. Kleinert H, Boissel JP, Schwarz PM, Förstermann U. Regulation of the expression of nitric oxide synthase isoforms. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 105-28.
142. Groves JT, Wang CC-Y. Nitric oxide synthase: models and mechanisms. Curr Opin Chem Biol 2000;4:687-95.
143. Moncada S. Cited in Stamler JS, Lamas S, Fang FC. Meeting review. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 2001;106:675-83.
144. Wang Y, Newton DC, Robb GB, et al. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc Natl Acad Sci 1999;96:12150-5.
145. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994;79:1137-46.
146. Casadei B, Sears CE. Nitric oxide-mediated regulation of cardiac contractility and stretch responses. Prog Biophys Mol Biol 2003;82:67-80.
147. Palamalai V, Darrow RM, Organisciak DT, Miyagi M. Light-induced changes in protein nitration in photoreceptor rod outer segments. Mol Vis 2006;12:1543-51.
148. Koniaris LG, McKillop LA, Schwartz SI, Zimmers TA. Liver regeneration. J Am Coll Surg 2003;197:634-9.
149. Guo FH, De Raeve HR, Stuehr DJ, et al. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci 1995;92:7809-13.
150. Hoffman RA, Zhang G, Nussler NC, et al. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol 1997;272:G383-92.
151. Gaston B, Reilly J, Drazen JM, et al. Endogenous nitrogen oxides and bronchodilator s-nitrosothiols in human airways. Proc Natl Acad Sci 1993;90:10957-61.
152. Crane BR, Arvai AS, Gachui R, et al. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 1997;278:425-31.
153. Crane BR, Arvai AS, Ghosh DK, et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998;279:2121-6.
154. Fischmann TO, Hruza A, Niu XD, et al. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol 1999;6:233-42.
155. Li H, Raman CS, Glaser CB, et al. Crystal structures of zinc-free and -bound heme domain of human inducible nitric oxide synthase. Implications for dimer stability and comparison with endothelial nitric oxide synthase. J Biol Chem 1999;274:21276-84.
156. Raman CS, Li H, Martasek P, Kral V, Masters BS, Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 1998;95:939-50.
157. Tierney DL, Huang H, Martasek P, et al. ENDOR studies of l-arginine and N-G-hydroxyl-l-arginine bound to all three holo-nitric oxide synthase isoenzymes. J Am Chem Soc 2000;122:5405-6.
158. Ganster RW, Geller DA. Molecular regulation of inducible nitric oxide synthase. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 129-56.
159. Hobbs AJ, Fukuto JM, Ignarro LJ. Formation of free nitric oxide from l-arginine by nitric oxide synthase; direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci 1994;91:10992-6.
160. Murphy ME, Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci 1991;88:10860-4.
161. Miller RT, Martasek P, Roman LJ. Involvement of the reductase domain of neuronal nitric oxide synthase in superoxide anion production. Biochemistry 1997;36:15277-84.
162. Xia Y, Zweier JL. Direct measurement of nitric oxide generation from nitric oxide synthase. Proc Natl Acad Sci 1997;94:12705-10.
163. Vasquez-Vivar J, Hogg N, Martasek P, et al. Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 1999;274:26736-42.
164. Vasquez-Vivar J, Kalyanaraman B, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci 1998;95:9220-5.
165. Rusche KM, Spiering MM, Marletta AA. Reactions catalysed by tetrahydrobiopterin-free nitric oxide synthase. Biochemistry 1998;37:15503-12.
166. List BM, Klosch B, Volker C, et al. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity; tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochem J 1997;323:159-65.
167. Stroes E, Hijmering M, Van Zandvoort M, et al. Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett 1998;438:161-4.
168. Xia Y, Roman LJ, Masters BS, Zweier JL. Inducible nitric oxide synthase generates superoxide from the reductase domain. J Biol Chem 1998;273:22635-9.
169. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite; implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 1990;87:1620-4.
170. Gross S, Levi R. Tetrahydrobiopterin synthesis. J Biol Chem 1992;267:25722-9.
171. Cosentino F, Patton S, d'Uscio LV, et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998;101:1530-7.
172. Stroes E, Kastelein J, Cosentino F, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997;99:41-6.
173. Wever RMF, van Dam T, van Rijn HJM, de Groot PG, Rabeliak TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthesis. Biochem Biophys Res Comm 1997;237:340-4.
174. Chen X, Reynolds ER, Ranganayakulu G, O'Donnell JM. A maternal product of the Punch locus of Drosophila melanogaster is required for precellular blastoderm nuclear division. J Cell Sci 1994;107:3501-13.
175. Gross SS, Jones LJ, Hattori Y, Raman CS. Tetrahydrobiopterin: an essential cofactor of nitric oxide synthase with an elusive role. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 167-86.
176. Visconti M, Karmer P. Fluoresziende Stoffe aus Drosophila melanogaster. Helv Chim Acta 1957;40:986.
177. Cory GJ. Purine and pyrimidine nucleotide metabolism. In: Devlin TM, editor. Textbook of biochemistry, with clinical correlations. New York: Wiley-Liss; 2006. pp 790-822.
178. Zhuo S, Fan S, Kaufman S. Effects of depletion of intracellular tetrahydrobiopterin in murine erythroleukemia cells. Exp Cell Res 1996;222:163-70.
179. Werner-Felmayer G, Goldferer G, Werner ER, Gröbner P, Wachter H. Pteridine biosynthesis and nitric oxide synthase in Physarum polycephalum. Biochem J 1994;304:105-11.
180. Wachter H, Fuchs D, Reibnegger G, Werner ER. Neopterin as a marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989;27:81-141.
181. Krehan A, Ansuini H, Böcher O, et al. Transcription factors, Ets-1, NFκB, and Sp1 are major determinants of the promoter activity of the human protein kinase CK2α gene. J Biol Chem 2000;275:18327-36.
182. Szabo C, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993;108(3):786-92.
183. Hoffer A. The effect of adrenochrome and adrenolutin on the behaviour of animals and the psychology of man. Int Rev Neurobiol 1962;4:307-71.
184. Hoffer A. Adrenochrome and blood plasma. Am J Psychiatr 1958;114:752-3.
185. Tracey KJ. The inflammatory reflex. Nature, Inflammation 2002;420:853-9.
186. Bolton CF, Young GB, Zochodne DW. Neurological changes during severe sepsis. In: Burchardii H, Dobb G, Biou J, Dellinger RF, editors. Current topics in intensive care. London: WB Saunders; 1994. pp 180-218.
187. Cohen J. The immunopathogenesis of sepsis. Nature, Inflammation 2002;420:885-9.
188. Scalabrino G, Carpo M, Bamonti F, et al. High tumor necrosis factor-α levels in cerebrospinal fluid of cobalamin-deficient patients. Ann Neurol 2004;56:886-90.
189. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360:219-23.
190. Morris SM. Regulation of arginine availability and its impact on NO synthesis. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 187-97.
191. Deitch EA, Specian RD, Berg RD. Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation and
192. Awad WM. Iron and heme metabolism. In: Devlin TM, editor. Textbook of biochemistry, with clinical correlations. New York: Wiley-Liss; 2006. pp 824-47.
193. Wang P, Zheng F, Chaudry IH. Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis. Am J Physiol 1995;269:R988-94.
194. Sun J, Xin C, Eu JP, Stamler JS, Meissner G. Cysteine 3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci 2001;98:11158-62.
195. Schmidt HHHW, Walter U. NO at work. Cell 1994;78:919-25.
196. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and veins. Circ Res 1989;65:1-21.
197. Ignarro LJ. Introduction and overview. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 3-19.
198. Salvemini D, Misko TP, Masferrer JL, et al. Nitric oxide activated cycloxygenase enzymes. Proc Natl Acad Sci 1993;90:7240-4.
199. Fukoto JM, Wallace GC, Hszieh R, Chandhuri G. Chemical oxidation of N-hydroxyguanidine compounds. Release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation. Biochem Pharmacol 1992b;43:607-13.
200. Murad F. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Rec Prog Horm Res 1994;49:239-48.
201. Boveris A, Poderoso JJ. Regulation of oxygen metabolism by nitric oxide. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 355-68.
202. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci 1993;90:11147-51.
203. Thomas SR, Mohr D, Stocker R. Nitric oxide inhibits indolamine 2, 3-dioxygenase activity in interferon-primed mononuclear phagocytes. J Biol Chem 1994;269:14457-64.
204. Molina J, Vedia L, MacDonald BR, Reep B, et al. Nitric oxide-induced s-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem 1992;267:24929-32.
205. Zhang J, Snyder SH. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci 1992;89:9382-5.
206. Gopalakrishna R, Hai Chen Z, Gundimeda U. Nitric oxide and nitric-oxide generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 1993;268:27180-5.
207. Stamler JS. S-nitrosothiols and bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr Top Microbiol Immunol 1995;196:19-36.
208. Laval F, Wink DA. Inhibition by nitric oxide of the repair protein, O6-DNA-methyltransferase. Carcinogenesis 1994;15:443-7.
209. Melino G, Bernassola F, Knight RA, et al. S-nitrosylation regulates apoptosis. Nature 1997;388:432-3.
210. Asahi M, Fujii J, Suzuki K, et al. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J Biol Chem 1995;270:21035-9.
211. Stamler JS, Simon DI, Jaraki O, et al. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl Acad Sci 1992;89:8087-91.
212. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an s-nitroso adduct of serum albumin. Proc Natl Acad Sci 1992;89:7674-7.
213. Stamler JS, Simon DI, Osborne JA, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci 1992;89:444-8.
214. Singh SP, Wishnok JS, Keshive M, Deen WM, Tannenbaum SR. The chemistry of the s-nitroso-glutathione/glutathione system. Proc Natl Acad Sci 1996;93:14428-33.
215. Ji Y, Akerboom TPM, Sies H, Thomas JA. S-Nitrosylation and S-glutathionylation of protein sulfhydryls by S-nitroso glutathione. Arch Biochem Biophys 1999;362:67-78.
216. Hausladen A, Fridovichi I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 1994;269:29405-8.
217. Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994;308:89-95.
218. Scott M, Meshnik S, Eaton J. Superoxide dismutase-rich bacteria. Paradoxical increase in oxidant toxicity. J Biol Chem 1987;262:3640-5.
219. Bloch C, Ausubel F. Paraquat-mediated selection for mutations in the manganese-superoxide dismutase gene sodA. J Bacteriol 1986;168:795-8.
220. Amstad P, Peskin A, Shah G, et al. Paraquat-mediated selection for mutations in the manganese-superoxide dismutase gene sodA. Biochemistry 1991;30:9305-13.
221. Mao G, Thomas P, Lopaschuk G, Poznansky M. Superoxide dismutase (SOD)-catalase conjugates. Role of hydrogen peroxide and the Fenton reaction in SOD toxicity. J Biol Chem 1993;268:416-20.
222. Amstad P, Moret R, Cerutti P. Glutathione peroxidase compensates for the hypersensitivity of Cu, Zn superoxide dismutase overproducers to oxidant stress. J Biol Chem 1994;269:1606-9.
223. Kelner M, Bagnell R. Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase, and glutathione transferase activity in cells transfected with a copper-zinc superoxide dismutase expression vector. Explanation for variations in paraquat resistance. J Biol Chem 1990;265:10872-95.
224. Staver PJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 2004;62:S3.
225. Mannervik B, Widersten M, Board PG. Glutathione-linked enzymes in detoxication reactions. In: Tamiguchi N, Higashi T, Sakanoto Y, Meister A, editors. Glutathione centennial, molecular perspectives and clinical implications. New York: Academic Press; 1989. pp 23-34.
226. Mannervik B, Carlberg I, Larson K. Glutathione: General Review of Mechanism of Action. In: Dolphin D, Avramovic O, Poulson R, editors. Glutathione chemical, biochemical and medical aspects, coenzymes and cofactors. Vol. 3A. New York: Wiley; 1989. pp 476-517.
227. Wink DA, Cook JA, Kim SY, et al. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem 1997;272:11147-51.
228. Brigelius R. Mixed disulfides: biological functions and increase in oxidative stress. In: Sies H, editor. Oxidative stress. London: Academic Press; 1985. pp 243-72.
229. Hamilos DL, Wedner HJ. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J Immunol 1985;135:2740-7.
230. Ling CT, Chow BF. Effect of vitamin B12 on the levels of soluble sulfhydryl compounds in blood. J Biol Chem 1953;202:445-56.
231. Register UD. The effect of vitamin B12 on liver and blood non-protein sulfhydryl compounds. J Biol Chem 1954;206:705-9.
232. Dubnoff JW, Bartron E. The effect of B12 on enzyme activity in E. coli mutant 113-3. Arch Biochem Biophys 1956;61:99-110.
233. 2-pyruvate exchange reaction: a reappraisal. J Biol Chem 1962;237:PC263-5.
234. Aronovitch J, Grossowicz N. Cobalamin catalyzed oxidation of sulfhydryl groups. Biochem Biophys Res Comm 1962;8:416-20.
235. Schrauzer GN, Windgassen RJ. On cobaloximes with cobalt-sulfur bonds and some model studies related to cobamide-dependent methyl-group-transfer reactions. J Am Chem Soc 1967;89:3607.
236. Jacobsen DW, Pezacka EH, Brown KL. The inhibition of corrinoid-catalyzed oxidation of mercaptoethanol by methyl iodide: mechanistic implications. J Inorg Biochem 1993;50:47-63.
237. Kuo P, Abe KY, Schroeder RA. Interleukin-I-induced nitric oxide production modulates glutathione synthesis in cultured rat hepatocytes. Am J Physiol 1996;271:C851-62.
238. Kharitonov VG, Sundquist AR, Sharma VS. Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J Biol Chem 1995;270:28158-64.
239. Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci 1998;95:7631-6.
240. Arteel GE, Briviba K, Sies H. Mechanisms of antioxidant defense against nitric oxide/peroxynitrite. In: Ignarro LJ, editor. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. pp 343-54.
241. Quijano C, Alvarez B, Gatti RM, Angusto O, Radi R. Pathways of peroxynitrite oxidation of thiol groups. Biochem J 1997;322:167-73.
242. Morris SL, Walsh RC, Hauser JN. Identification and characterization of some bacterial membrane sulfhydryl groups which are targets of bacteriostatic and antibiotic action. J Biol Chem 1984;259:13590-4.
243. Gilbert HS. Proposal of a possible function for granulocyte vitamin B12 binding proteins in host defense against bacteria. Blood 1974;44:926.